ClinicalTrials.gg
Not yet recruitingNCT07839780SPRG-WSLUpdated Sep 24, 2026

S-PRG Filler for Preventing White Spot Lesions During Orthodontic Treatment

An interventional study of S-PRG Barrier Coat and S-PRG Barrier Coat + 5% Sodium Fluoride Varnish in White Spot Lesion of Tooth, Orthodontic Treatment and Enamel Demineralization, sponsored by National University of Malaysia. Not yet recruiting at 1 site in Malaysia. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by National University of Malaysia · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
144
Allocation
Randomized
Sex
All
01

Study summary

White spot lesions are early areas of enamel demineralization that may develop during orthodontic treatment with fixed braces. This study aims to evaluate the effectiveness of S-PRG Barrier Coat in preventing white spot lesions during orthodontic treatment. The study will compare S-PRG Barrier Coat with 5% sodium fluoride varnish, a combination of S-PRG Barrier Coat and 5% sodium fluoride varnish, and a placebo. A total of 144 participants undergoing orthodontic treatment will be randomly assigned to one of four treatment groups. The occurrence and severity of white spot lesions will be assessed using clinical examinations, including the ICDAS-II and Gorelick index, together with DIAGNOdent readings where applicable. The study findings may help determine whether S-PRG Barrier Coat provides an effective preventive approach against orthodontic white spot lesions.

Read the detailed description

White spot lesions (WSLs) are early manifestations of enamel demineralization that may occur during orthodontic treatment with fixed appliances. Brackets and archwires can increase plaque accumulation and make oral hygiene more difficult, potentially increasing the risk of enamel demineralization. Although fluoride-based preventive measures are commonly used, additional preventive approaches may be beneficial.

S-PRG (Surface Pre-Reacted Glass-ionomer) bioactive fillers have the potential to release various ions, including fluoride and strontium, which may contribute to the inhibition of demineralization and promotion of remineralization. S-PRG Barrier Coat is therefore being investigated as a potential preventive material for orthodontic WSLs.

Study Objective

The objective of this study is to evaluate the effect of S-PRG Barrier Coat in preventing white spot lesions during orthodontic treatment. Its preventive effect will be compared with 5% sodium fluoride varnish, a combination of S-PRG Barrier Coat and 5% sodium fluoride varnish, and a placebo.

Study Design

This is a single-center, four-arm, parallel-group, randomized controlled clinical trial involving patients undergoing orthodontic treatment with fixed appliances. A total of 144 participants will be recruited and randomly allocated in a 1:1:1:1 ratio to four treatment groups, with 36 participants planned for each group.

Intervention Groups

S-PRG Barrier Coat. 5% sodium fluoride varnish. Combined S-PRG Barrier Coat and 5% sodium fluoride varnish. Placebo.

Study Procedures and Assessments

Eligible participants will be recruited from the orthodontic clinic following assessment against the study inclusion and exclusion criteria. Written informed consent will be obtained before participation. Baseline assessments will be conducted according to the study protocol, followed by the application of the assigned intervention.

Participants will be followed during orthodontic treatment to assess the occurrence and severity of WSLs. Clinical assessments will include the International Caries Detection and Assessment System (ICDAS-II) and the Gorelick index. DIAGNOdent readings may also be used as a diagnostic assessment of enamel demineralization, according to the approved study protocol. Clinical and diagnostic findings will be recorded and compared among the treatment groups.

Randomization and Blinding

Participants will be randomly allocated to one of the four treatment groups. The study is designed as a double-blind randomized controlled trial. The specific individuals blinded to treatment allocation will follow the approved study protocol.

Expected Contribution

This study may provide evidence on whether S-PRG Barrier Coat, alone or in combination with fluoride varnish, offers a preventive benefit against orthodontic WSLs compared with fluoride varnish alone and placebo. The findings may contribute to the development of preventive strategies for enamel demineralization during orthodontic treatment.

02

Conditions studied

  • White Spot Lesion of Tooth
  • Orthodontic Treatment
  • Enamel Demineralization
  • Fluoride Varnishes

Keywords

  • White spot lesions
  • Orthodontic treatment
  • Enamel demineralization
  • S-PRG Barrier Coat
  • Surface Pre-Reacted Glass-ionomer
  • Remineralization
  • Fluoride varnish
03

In context

Lead sponsor

National University of Malaysia is the lead sponsor of 124 studies on the registry; 45 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients scheduled to undergo fixed orthodontic treatment at the Faculty of Dentistry, Universiti Kebangsaan Malaysia (UKM), who provide . For participants below 18 years of age, parental or guardian consent will be obtained.
  2. Patients receiving orthodontic brackets on at least the upper incisors and canines, with an anticipated treatment duration of at least 12 months.
  3. Patients with any degree of malocclusion.
  4. Patients without pre-existing white spot lesions on the teeth being assessed.
  5. Medically fit and healthy patients.
  6. Non-smokers.
  7. Patients who can understand and communicate in basic English or Bahasa Malaysia

Exclusion criteria

Exclusion Criteria:

  1. Previous history of fixed orthodontic treatment.
  2. Presence of dental anomalies or developmental defects of enamel (DDE) on the labial surfaces of the teeth, including pre-existing fluorosis or enamel hypoplasia.
  3. Presence of direct or indirect restorations on the labial surfaces of the teeth being assessed.
  4. History of long-term antibiotic use.
  5. Presence of untreated cavitated carious lesions, particularly involving the upper or lower incisors and canines.
  6. Plaque level greater than 30%.
  7. Known allergy to any component of the intervention materials, including sodium fluoride or glass ionomer.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
144 participants (estimated)

Study arms

  • Active comparator
    5% Sodium Fluoride Varnish

    Participants receive 5% sodium fluoride varnish as the active comparator during orthodontic treatment with fixed appliances.

    Other: 5% sodium fluoride varnish

  • Experimental
    S-PRG + 5% Sodium Fluoride Varnish

    Participants receive the combined S-PRG Barrier Coat and 5% sodium fluoride varnish intervention during orthodontic treatment with fixed appliances.

    Combination Product: S-PRG Barrier Coat + 5% Sodium Fluoride Varnish

  • Placebo comparator
    Placebo-Normal Saline

    Participants receive a placebo (normal saline) during orthodontic treatment with fixed appliances.

    Other: Placebo - Normal Saline

  • Experimental
    S-PRG Barrier Coat

    Participants receive S-PRG Barrier Coat as the assigned preventive intervention during orthodontic treatment

    Other: S-PRG Barrier Coat

Interventions

  • OtherS-PRG Barrier Coat

    S-PRG Barrier Coat is a surface pre-reacted glass-ionomer (S-PRG) bioactive coating applied to tooth surfaces around orthodontic brackets according to the study protocol. It is intended to reduce enamel demineralization and prevent the development of white spot lesions during fixed orthodontic treatment.

  • Combination productS-PRG Barrier Coat + 5% Sodium Fluoride Varnish

    A combined preventive treatment consisting of S-PRG Barrier Coat and 5% sodium fluoride varnish applied according to the study protocol to reduce enamel demineralization and prevent the development of white spot lesions during fixed orthodontic treatment.

  • Other5% sodium fluoride varnish

    5% sodium fluoride varnish applied to the tooth surfaces according to the study protocol as an active comparator for prevention of enamel demineralization and development of white spot lesions during fixed orthodontic treatment.

  • OtherPlacebo - Normal Saline

    Normal saline used as the placebo comparator and applied according to the study protocol to the tooth surfaces during fixed orthodontic treatment. The placebo is intended to provide a comparable application procedure without the active preventive components of the study interventions.

06

What researchers measure

Primary outcomes

  1. Occurrence of White Spot Lesions During Orthodontic Treatment

    The occurrence of white spot lesions will be assessed clinically using the International Caries Detection and Assessment System (ICDAS-II) and the Gorelick index. The presence or absence of white spot lesions will be compared among the four treatment groups.

    Time frame: 12 months after initiation of orthodontic treatment

Secondary outcomes

  1. Comparative Effectiveness of S-PRG Filler and 5% Sodium Fluoride Varnish in Preventing White Spot Lesions Assessed by ICDAS-II

    To compare the effectiveness of S-PRG filler and 5% sodium fluoride varnish in preventing the occurrence of white spot lesions in patients undergoing fixed orthodontic treatment. White spot lesion occurrence will be assessed using the ICDAS-II scoring system.

    Time frame: 12 months after initiation of fixed orthodontic treatment.

Other outcomes

  1. Comparative Effectiveness of S-PRG Filler and 5% Sodium Fluoride Varnish in Preventing White Spot Lesions Assessed by the Gorelick Index

    To compare the effectiveness of S-PRG filler and 5% sodium fluoride varnish in preventing white spot lesions in patients undergoing fixed orthodontic treatment. White spot lesion severity will be assessed from standardized digital photographs using the Gorelick index.

    Time frame: 12 months after initiation of fixed orthodontic treatment.

  2. Comparative Effectiveness of S-PRG Filler and 5% Sodium Fluoride Varnish in Preventing White Spot Lesions Assessed by DIAGNOdent

    To compare changes in DIAGNOdent fluorescence values between S-PRG filler and 5% sodium fluoride varnish groups during fixed orthodontic treatment.

    Time frame: 12 months after initiation of Orthodontic treatment

07

Study locations

1 site
08

References and documents

Publications

  • Al Tuma, R. R. & Yassir, Y. A. 2023. Effect of calcium fluoride nanoparticles in prevention of demineralization during orthodontic fixed appliance treatment: a randomized clinical trial. Eur J Orthod 45(2): 122-132. Altenburger, M. J., Schirrmeister, J. F., Wrbas, K. T., Klasser, M. & Hellwig, E. 2008. Fluoride uptake and remineralisation of enamel lesions after weekly application of differently concentrated fluoride gels. Caries Res 42(4): 312-318. Amaechi, B. T., Kasundra, H., Joshi, D., Abdollahi, A., Azees, P. a. A. & Okoye, L. O. 2018. Effectiveness of S-PRG Filler-Containing Toothpaste in Inhibiting Demineralization of Human Tooth Surface. Open Dentistry Journal 12(811-819. Anderson, A. M., Kao, E., Gladwin, M., Benli, O. & Ngan, P. 2002. The effects of argon laser irradiation on enamel decalcification: An in vivo study. Am J Orthod Dentofacial Orthop 122(3): 251-259. Benham, A. W., Campbell, P. M. & Buschang, P. H. 2009. Effectiveness of pit and fissure sealants in reducing white spot lesions during orthodontic treatment. A pilot study. Angle Orthod 79(2): 338-345. Benjasuwantep, P., Rirattanapong, P. & Vongsavan, K. 2017.. Southeast Asian Journal of Tropical Medicine and Public Health 48(5): 1127-1132. Bishara, S. E. & Ostby, A. W. 2008. White Spot Lesions: Formation, Prevention, and Treatment. Seminars in Orthodontics 14(3): 174-182. Brown, M. D., Campbell, P. M., Schneiderman, E. D. & Buschang, P. H. 2016. A practice-based evaluation of the prevalence and predisposing etiology of white spot lesions. Angle Orthod 86(2): 181-186. Buchalla, W., Attin, T., Schulte-Mönting, J. & Hellwig, E. 2002. Fluoride uptake, retention and remineralization efficacy of a highly concentrated fluoride solution on enamel lesions . Journal of Dental Research 81(5): 329-333. Buren, J. L., Staley, R. N., Wefel, J. & Qian, F. 2008. Inhibition of enamel demineralization by an enamel sealant, Pro Seal: an in-vitro study. Am J Orthod Dentofacial Orthop 133(4 Suppl): S88-94. Chapman,

Individual participant data

Plan to share: No — Individual participant data will not be shared with other researchers because the study involves confidential participant information.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Dec 2027, 14 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 17, 2026
First posted
Sep 24, 2026
StartEst.
Oct 2026
Primary completionEst.
Dec 2027
CompletionEst.
Jan 2028
Last update
Sep 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07839780
Responsible party
Dr. Noor Sam bin Ahmad (DR, National University of Malaysia) — Principal investigator
First posted
Sep 24, 2026
Start date
Oct 2026 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Jan 2028 (estimated)
Last update
Sep 24, 2026

Study contacts

DAVEINTHIRAN THANABALAN, Bachelor of Dental Surgery
Contact
p166299@siswa.ukm.edu.my
+60173807427
NOOR SAM AHMAD, MOrth (UKM)
Contact
+60193353958

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion